Daniil Gataulin
Stock Analyst at Chardan Capital
(2.12)
# 2,845
Out of 4,893 analysts
95
Total ratings
44.83%
Success rate
n/a
Average return
Main Sectors:
Top Industries:
Stocks Rated by Daniil Gataulin
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| OCGN Ocugen | Maintains: Buy | $7 | $1.15 | +508.70% | 12 | Jun 24, 2025 | |
| FBRX Forte Biosciences | Maintains: Buy | $61 | $11.35 | +437.44% | 5 | Jun 24, 2025 | |
| RGNX REGENXBIO | Maintains: Buy | $52 | $9.08 | +472.69% | 11 | Jun 9, 2025 | |
| QURE uniQure | Maintains: Buy | $38 | $14.90 | +155.03% | 4 | May 30, 2025 | |
| ADVM Adverum Biotechnologies | Maintains: Buy | $33 | $2.72 | +1,113.24% | 7 | May 15, 2025 | |
| MGTX MeiraGTx Holdings | Maintains: Buy | $38 → $35 | $8.62 | +306.03% | 4 | May 14, 2025 | |
| CRVO CervoMed | Maintains: Buy | $14 → $15 | $7.21 | +108.04% | 6 | May 12, 2025 | |
| OCS Oculis Holding AG | Maintains: Buy | $28 → $33 | $18.31 | +80.23% | 7 | May 9, 2025 | |
| EYPT EyePoint Pharmaceuticals | Maintains: Buy | $33 → $27 | $11.06 | +144.12% | 11 | May 8, 2025 | |
| CGTX Cognition Therapeutics | Maintains: Buy | $8 → $4 | $0.70 | +471.67% | 7 | May 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $70 | $17.35 | +303.57% | 2 | May 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $4 | $0.10 | +3,860.40% | 4 | Apr 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $6 | $0.87 | +589.50% | 4 | Mar 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $3 | $2.02 | +48.51% | 8 | Feb 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $220 | $2.52 | +8,630.16% | 1 | Mar 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $4.48 | - | 2 | Jul 25, 2023 |
Ocugen
Jun 24, 2025
Maintains: Buy
Price Target: $7
Current: $1.15
Upside: +508.70%
Forte Biosciences
Jun 24, 2025
Maintains: Buy
Price Target: $61
Current: $11.35
Upside: +437.44%
REGENXBIO
Jun 9, 2025
Maintains: Buy
Price Target: $52
Current: $9.08
Upside: +472.69%
uniQure
May 30, 2025
Maintains: Buy
Price Target: $38
Current: $14.90
Upside: +155.03%
Adverum Biotechnologies
May 15, 2025
Maintains: Buy
Price Target: $33
Current: $2.72
Upside: +1,113.24%
MeiraGTx Holdings
May 14, 2025
Maintains: Buy
Price Target: $38 → $35
Current: $8.62
Upside: +306.03%
CervoMed
May 12, 2025
Maintains: Buy
Price Target: $14 → $15
Current: $7.21
Upside: +108.04%
Oculis Holding AG
May 9, 2025
Maintains: Buy
Price Target: $28 → $33
Current: $18.31
Upside: +80.23%
EyePoint Pharmaceuticals
May 8, 2025
Maintains: Buy
Price Target: $33 → $27
Current: $11.06
Upside: +144.12%
Cognition Therapeutics
May 8, 2025
Maintains: Buy
Price Target: $8 → $4
Current: $0.70
Upside: +471.67%
May 5, 2025
Maintains: Buy
Price Target: $70
Current: $17.35
Upside: +303.57%
Apr 23, 2025
Maintains: Buy
Price Target: $4
Current: $0.10
Upside: +3,860.40%
Mar 28, 2025
Maintains: Buy
Price Target: $6
Current: $0.87
Upside: +589.50%
Feb 18, 2025
Maintains: Neutral
Price Target: $3
Current: $2.02
Upside: +48.51%
Mar 7, 2024
Maintains: Buy
Price Target: $220
Current: $2.52
Upside: +8,630.16%
Jul 25, 2023
Downgrades: Neutral
Price Target: n/a
Current: $4.48
Upside: -